XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Of Financial Instruments (Tables)
9 Months Ended
Mar. 31, 2021
Fair Value Of Financial Instruments [Abstract]  
Schedule Of Key Valuation Inputs Used To Measure Fair Value Of Investment In Cell C

 

Weighted Average Cost of Capital ("WACC"):

Between 16% and 24% over the period of the forecast

 

Long term growth rate:

3% (3% as of June 30, 2020)

 

Marketability discount:

10%

 

Minority discount:

15%

 

Net adjusted external debt - March 31, 2021:(1)

ZAR 11.4 billion ($0.8 billion), no lease liabilities included

 

Net adjusted external debt - June 30, 2020:(2)

ZAR 15.8 billion ($0.9 billion), includes ZAR4.4 billion of lease liabilities

 

Deferred tax (incl, assessed tax losses) - March 31, 2021:(1)

ZAR 0 ($0)

 

Deferred tax (incl, assessed tax losses) - June 30, 2020:(2)

ZAR 2.9 billion ($167.3 million)

(1) translated from ZAR to U.S. dollars at exchange rates applicable as of March 31, 2021.

(2) translated from ZAR to U.S. dollars at exchange rates applicable as of June 30, 2020.

Schedule Of Impact On Carrying Value Of Cell C Investment

 

Sensitivity for fair value of Cell C investment

 

3.0% increase

 

2.5% decrease

 

 

WACC rate

$

-

$

3,349

 

 

EBITDA margin

$

2,134

$

-

 

Fair Value Of Assets And Liabilities Measured On Recurring Basis

 

 

 

 

 

 

Quoted Price in Active Markets for Identical Assets

(Level 1)

 

 

Significant Other Observable Inputs

(Level 2)

 

 

Significant Unobservable Inputs

(Level 3)

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment in Cell C

$

-

 

$

-

 

$

-

 

$

-

 

 

Related to insurance business:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash, cash equivalents and restricted cash (included in other long-term assets)

 

441

 

 

-

 

 

-

 

 

441

 

 

 

Fixed maturity investments (included in cash and cash equivalents)

 

2,655

 

 

-

 

 

-

 

 

2,655

 

 

 

Total assets at fair value

$

3,096

 

$

-

 

$

-

 

$

3,096

 

 

 

 

 

 

 

Quoted Price in Active Markets for Identical Assets

(Level 1)

 

 

Significant Other Observable Inputs

(Level 2)

 

 

Significant Unobservable Inputs

(Level 3)

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment in Cell C

$

-

 

$

-

 

$

-

 

$

-

 

 

Related to insurance business

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents (included in other long-term assets)

 

490

 

 

-

 

 

-

 

 

490

 

 

 

Fixed maturity investments (included in cash and cash equivalents)

 

4,198

 

 

-

 

 

-

 

 

4,198

 

 

 

 

Total assets at fair value

$

4,688

 

$

-

 

$

-

 

$

4,688

 

Carrying Value Of Assets And Liabilities Measured On Recurring Basis

 

 

 

 

 

 

Carrying value

 

 

Assets

 

 

 

 

Balance as of June 30, 2020

$

-

 

 

 

Foreign currency adjustment(1)

 

-

 

 

 

 

Balance as of March 31, 2021

$

-

 

(1) The foreign currency adjustment represents the effects of the fluctuations between the ZAR, and the U.S. dollar on the carrying value.

 

 

 

 

 

 

Carrying value

 

 

Assets

 

 

 

 

Balance as at June 30, 2019

$

-

 

 

 

Foreign currency adjustment(1)

 

-

 

 

 

 

Balance as of March 31, 2020

$

-

 

(1) The foreign currency adjustment represents the effects of the fluctuations between the ZAR, and the U.S. dollar on the carrying value.